Greer Pharmaceuticals

Stallergenes Greer is a global biopharmaceutical company specializing in the development and commercialization of allergy immunotherapy (AIT) products and services. Formed through the 2015 merger of the French firm Stallergenes and the American company Greer Laboratories, it is a leader in the allergy treatment market. The company provides a comprehensive portfolio of allergen extracts for subcutaneous and sublingual administration, catering to a wide range of environmental and seasonal allergies. Its flagship products include Oralair, a sublingual immunotherapy tablet for grass pollen allergy, and various customized allergen extracts. Stallergenes Greer operates major manufacturing and research facilities in Lenoir, North Carolina, and Antony, France, ensuring a robust supply chain for global markets. The company focuses on personalized medicine, offering diagnostic tools and tailored treatments to improve the quality of life for patients with severe respiratory allergies.